Hecla Mining well-positioned for growth after 2024 results, says H.C. Wainwright
H.C. Wainwright analyst Heiko Ihle reiterates a Buy rating on Hecla Mining (HL) shares after the company reported 2024 financial results. The ...
Coinbase price target raised to $350 from $330 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Coinbase (COIN) to $350 from $330 and keeps a Buy rating on the shares. The firm says the ...
What is HC Wainwright’s Forecast for CRBP FY2029 Earnings?
Analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Monday, February 10th. HC Wainwright analyst A. Maldonado expects ...
HC Wainwright Reaffirms “Buy” Rating for Aptose Biosciences (NASDAQ:APTO)
Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They ...
Ocugen shares rise as H.C. Wainwright lifts price target to $8
H.C. Wainwright analyst raised the price target on Ocugen, Inc. (NASDAQ:OCGN) to $8.00, up from the previous $7.00, while maintaining a Buy rating on the stock. Currently trading at $0.66, the stock ...
H.C. Wainwright cuts Compass Pathways stock target to $45
H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...